Delivery Order SPE2DB20D7061-SPE2DB24FSNL7
- Not listed
- This federal contract award, valued at $4,911.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 0.5% Ophthalmic Solution, a medication used to treat eye pain and inflammation. This is a Firm Fixed Price Delivery Order contract with a completion date of January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $7,542.83 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564247323 - Ketorolac 0.5% Ophthalmic Solution 5ML. The contract has an ultimate completion date of April 12, 2024. This delivery order is issued under Amerisourcebergen's single-award indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,587.10, was awarded by the Defense Logistics Agency (DLA) for the delivery of Ketorolac 0.5% ophthalmic solution, a medication commonly used to treat eye-related pain and inflammation. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of December 13, 2024. This award is not...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ketorolac 0.5% ophthalmic solution in 10 ml bottles. The $3,564.79 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, on April 15, 2024, with a planned completion date of April 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $3,044.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ketorolac 0.5% ophthalmic solution, a prescription medication used to treat eye inflammation. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,416.00 firm fixed-price delivery order is for the supply of Ketorolac 0.5% ophthalmic solution 5ml. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Ketorolac 0.5% ophthalmic solution in 10 mL vials. The contract has a ceiling value of $2,520.00 and is a delivery order placed under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which is valued at up to $999,999,999.00 through December 31, 2025. The DLA IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award, with ID SPE2DX15D1022|SPE2DX24FVEMP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ketorolac 0.4% ophthalmic solution, a pain management medication, with a ceiling value of $3,540.13. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on March 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
- This federal contract award, with an identifier of SPE2DB22D3016|SPE2DB24FBDJ4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ketorolac 0.4% ophthalmic solution, a medication used to treat eye pain and inflammation. It is a firm-fixed-price delivery order contract with a ceiling value of $1,114.09 and a completion date of August 9, 2024. The contract does not have a set-aside designation....
- The Defense Logistics Agency awarded a delivery order valued at $1,597.72 to AmerisourceBergen Drug Corp for the supply of Ketorolac 0.4% Ophthalmic Solution in 5mL quantities. This contract was awarded on November 3, 2025, under a firm fixed-price delivery order with an ultimate completion date of November 4, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB24FSNL7Delivery Order
This federal contract award is for the delivery of Ketorolac 0.4% ophthalmic solution, a prescription eye medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a firm fixed-price basis for a total ceiling value of $2,047.08. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current contract has no set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 5/21/24 |